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Errata and Corrigenda 
The publishers and the authors would like to make the following corrections: 
Lumb, K.J., Aplin, R.T., Radford, S.E., Archer, D.B., Jeenes, D. J., Lambert, N., MacKenzie, D.A., Dobson, CM. 
and Lowe, G., A study of D52S hen lysozyme-GlcNAc oligosaccharide complexes by NMR spectroscopy and 
electrospray mass spectrometry (1992) FEBS Letters 296, 1533157. 
The resonance labeled “62” in Fig. la should have been labeled “63” and the resonance labeled “63” in Fig. la should 
have been labeled “62”. The other labels in Fig. la and all the labels in Fig. lb were correct. 
Majetschak, M., Laub, M. and Jennissen, H.P., A ubiquityl-calmodulin synthetase that effectively recognizes the 
Ca’+-free form of calmodulin (1993) FEBS Letters 315, 347-352. 
Section 2.1. Preparative methods; the second sentence should have read: 
“Reticulocyte APF II (ATP-dependent proteolysis fraction II) was prepared at 5°C as described in ref. [1,14], except 
that the lysate (ca. 300400 ml) was applied to a Fractogel-EMD-DEAE 650 S Superformance column (1 .O cm i.d. 
5 15.0 cm gel height; Merck Darmstadt) instead of to DEAE Sephacel (Pharmacia).” 
In Table I, Step 2 - APF III should be replaced by APF II 
Step 3 - Ub-Sepharoze should be replaced by Ub-Sepharose. 
Young, S.W., Poole, R.C., Hudson, A.T., Halestrap, A.P., Denton, R.M. and Tavare, J.M., Effects of tyrosine kinase 
inhibitors on protein kinase-independent systems (1993) FEBS Letters 316, 278-282. 
As the result of a typographical error the title and legend to Tabel I were missing. On the following page this table 
has been reprinted complete with title and legend. 
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Table 1 
Potency of tyrosine kinase inhibitors. 
March 1993 
Inhibitor name Mitochondrial 
uncouplings 
Lactate transportb Aldehyde 
dehydrogenasebf 
RG50864 50.0 f 0.9 126*7f 19.8 * 1.1 
NH2 
ST27 1 27.6 f 1.8 7.2 f l.Of > 1ooc 
(cH&CH 
ST638 58.1 f 7.6 46.6 f 9.2e 6.0 f 0.8 
(0.50 * 0.06) 
OH 
Erbstatin N.E. 132 f 34e N.E. 
(0.60 f 0.10) 
Genistein 68.9 * 2.8 8.5 f 2.Of 30 f 3.0 
The table summarizes the ECsO values @M) for uncoupling of oxidative phosphorylation by isolated liver mitochondria or the inhibition of 
insulin-dependent exogenous substrate phosphorylation by human insulin receptors, lactate transport into rat erythrocytes and the activity of 
purified aldehyde dehydrogenase. “Values represent means + S.E.M. for at least two separate experiments with a minimum of 6 inhibitor 
concentrations for each determination. bDerived parameter values f SE. for single experiments performed with at least six inhibitor concentrattons. 
‘Accurate rates could not be determined at inhibitor concentrations above 100 PM due to high absorbance at A,,,. Data were analysed by dlinear 
regression analysis or by non-linear least-squares regression analysis fitted using ‘the equatton V = V,/( 1 + (II&J”) where V is the observed rate, 
V, is the rate in the absence of inhibitor, I the concentration of inhibitor, K,, the concentration required for 50% inhibition (EC,,) and n is the 
Hill coefficient which is given in parenthesis or ‘the equation V = V,/(l + I/K,,,). N.E., no detectable effect. Assay conditions are given in 
Section 2. 
The authors and publishers apologise for any inconvenience these errors may have caused. 
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